Sequenom Eyes Sales Force Expansion, Reimbursement for Down Syndrome Test

The firm is looking to hire 150 to 175 reps focused on the obstetrics/gynecology market in the US for its SEQureDx Down Syndrome test that it intends to launch in June. It also is discussing reimbursement levels with insurance carriers in advance of the launch.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories